Blue Cone Monochromacy: The X-Linked Cause of Poor Vision, Nystagmus, and a Normal-Looking Fundus

Blue cone monochromacy (BCM) is a rare X-linked recessive cone disorder in which only the blue (S) cones and the rods function.

It presents in infancy with poor vision, nystagmus, and light sensitivity, and the fundus is often normal, which delays the diagnosis.

Recognizing it matters for genetic counselling and, increasingly, for gene therapy trials.

---

What Is Blue Cone Monochromacy?

The disorder results from loss of function of the long-wavelength (L) and medium-wavelength (M) opsin genes on the X chromosome.

The cause may be a deletion of the locus control region that regulates both genes, or a mutation that inactivates the L and M opsin genes.

In males with the disorder, the L and M cones are nonfunctional, and vision depends on S cones, which are few and sparse in the fovea, and on rods.

Female carriers are usually asymptomatic, but they may have mild abnormalities on testing.

Clinical Features

• Reduced central vision, usually between 20/80 and 20/200, and stable in childhood
• Pendular nystagmus in infancy, which often decreases with age
• Photophobia, particularly in bright light
• Myopia, which can be high, and astigmatism
• Severe color vision deficiency, with a characteristic confusion pattern
• A normal fundus in children, and later macular changes in some adults

A patient with BCM can have better vision at dusk, because the rods are less affected by the lack of cone function.

Progressive macular atrophy has been described in older individuals.

Differential Diagnosis

• Rod monochromacy (achromatopsia): autosomal recessive, with absence of all cone function, more severe photophobia, and a flat S-cone response (see achromatopsia)
• Cone and cone-rod dystrophy: progressive loss and a macular change (see cone-rod dystrophy)
• Albinism: iris transillumination and foveal hypoplasia (see albinism and foveal hypoplasia)
• Infantile nystagmus syndrome and Leber congenital amaurosis

Investigations

The electroretinogram is key: the photopic, cone-driven response is absent or severely reduced, the rod response is normal, and a specific S-cone ERG shows a preserved response (see electroretinography).

OCT may show a preserved or slightly disrupted ellipsoid zone in the fovea, with a normal foveal contour in many patients.

Color testing shows a tritan-like pattern, and the anomaloscope test is abnormal.

Molecular testing for the L and M opsin gene cluster confirms the diagnosis and provides the basis for family counselling.

Management

No treatment cures the condition, so care aims to optimize vision and comfort.

Correct refractive error, and consider tinted or filter lenses, or a red-tinted contact lens, to reduce glare.

Low-vision services and educational support help children to use their remaining vision.

Genetic counselling should explain the X-linked pattern, in which the sons of a carrier have a 50 percent chance of being affected.

Gene therapy trials for the disease have been undertaken, and families can be told about research opportunities (see gene therapy for inherited retinal disease).

Diagnosis in Practice

The history of poor vision since infancy, nystagmus, photophobia, and a normal-appearing fundus in a boy should raise the possibility of a cone disorder, and the family history may show affected maternal relatives.

The first test is usually the ERG, performed by a center that can include a flicker test and an S-cone stimulus.

In infants, the ERG can be performed under sedation, and the results guide the genetic work-up.

Genetic testing identifies the cause and allows the family to be counselled, and it should be considered a routine step in the diagnostic pathway.

Color Vision Findings

Patients with BCM can often distinguish blue from yellow at a particular level of brightness, but they confuse red, orange, yellow, and green.

They use brightness cues, and their performance on color tests is erratic.

Tests such as the Farnsworth D-15 and the anomaloscope show a typical pattern, but the diagnosis does not depend on them.

Visual Function and Day-to-Day Life

Photophobia is a daily problem, and tinted lenses with a red or dark filter, a wide-brimmed hat, and shaded environments help.

Children benefit from large print, high-contrast materials, and assistance in school.

Many patients are comfortable in dim light, and they perform better in the evening.

Nystagmus usually improves with age, and a head posture at the null point may be used.

Research and Gene Therapy

Gene therapy approaches to restore L and M cone function are in early stages, and some trials in patients with BCM have been conducted.

Families should be put in touch with registries and specialist centers if they wish to participate.

Remind families that natural history data matter, and that regular follow-up with imaging and visual function tests contributes to understanding the condition.

---

References

1. Nathans J, Davenport CM, Maumenee IH, et al. Molecular genetics of human blue cone monochromacy. Science. 1989;245:831-838.
2. Michaelides M, Johnson S, Simunovic MP, et al. Blue cone monochromatism: a phenotype and genotype assessment with evidence of progressive loss of cone function in older individuals. Eye. 2005;19:2-10.
3. Ryan SJ, Schachat AP, Wilkinson CP, et al, eds. Retina. 6th ed. Elsevier; 2018.
4. American Academy of Ophthalmology. Basic and Clinical Science Course, Section 12: Retina and Vitreous. AAO; current edition.